Skip to Content

Integrated Biopharma Inc INBP Stock Quote

| Rating as of


Last close prices updated as of Feb 08, 2023, 1:28 PM EST | USD
  • Last Close 0.2705
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Investment Style
  • Day Range 0.30  –  0.34
  • Year Range 0.27  –  1.01
  • Market Cap 10.1829 Mil
  • Volume / Avg 5,525.0 /  3,914.2
  • Price / Sales 0.15
  • Price / Book 0.44
  • Forward Div Yield 3.10%
  • Trailing Div Yield

Morningstar‘s Stock Analysis INBP

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics INBP

Company Profile INBP

Business Description

Integrated Biopharma Inc is a pharmaceutical company engaged in manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. It operates in two segments; Contract Manufacturing and Other Nutraceutical Businesses. It serves the needs of the nutraceutical industry by directly doing business as Chem International Inc. and through its operating subsidiaries; Manhattan Drug Company, Inc., AgroLabs, Inc., IHT Health Products, Inc. and MDC Warehousing and Distribution, Inc. The company generates maximum revenue from the Contract Manufacturing segment. The business operates and generates the majority of revenue from the United States.

225 Long Avenue, Building 15
Hillside, NJ, 07205
Industry Packaged Foods
Employees 147

FAQs for Integrated Biopharma Inc Stock

Yes. INBP has a forward dividend yield of 3.10%. See INBP’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

INBP’s market cap is 10.18 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

INBP’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare INBP’s historical performance against its industry peers and the overall market.